Prot# GAO4915g: A Phase II, Open-Label, Multicenter Study of Efficacy, Safety, And Biomarkers in Patients With Previously Untreated Advanced Diffuse Large B-cell Lymphoma Treated with GA101 (RO5072759) in Combination With Chop Chemotherapy

Project: Research project

Project Details

StatusFinished
Effective start/end date12/15/11 → 12/15/14

Funding

  • Genentech, Inc. (GAO4915g)